Entera Bio (ENTX) Gross Profit (2019 - 2024)

Entera Bio (ENTX) has reported Gross Profit for 5 consecutive years, with $9000.0 the latest figure, recorded in Q2 2024.

• Quarterly Gross Profit changed N/A year-over-year to $9000.0 in Q2 2024, while the trailing twelve-month figure through Mar 2025 was $9000.0 (changed N/A YoY) and the FY2024 annual result came in at $9000.0, changed N/A from the prior year.
• Gross Profit climbed to $9000.0 in Q2 2024 per ENTX's latest filing, from $6000.0 in the prior quarter.
• Over the last five years, Gross Profit for ENTX reached as high as $84000.0 in Q1 2021 and fell as low as $2000.0 in Q3 2022.
• A 4-year average of $26100.0 and a median of $12500.0 in 2022 frame the typical range for Gross Profit.
• Annual changes were most pronounced in 2020 — Gross Profit surged 75.0% — and 2022, when it slumped 97.33%.
• Year by year, Gross Profit stood at $21000.0 in 2020, then soared by 38.1% to $29000.0 in 2021, then slumped by 79.31% to $6000.0 in 2022, then jumped by 50.0% to $9000.0 in 2024.
• According to Business Quant data, Gross Profit over the past three periods registered $9000.0, $6000.0, and $2000.0 for Q2 2024, Q4 2022, and Q3 2022 respectively.